|
BE615511A
(enExample)
|
1961-03-25 |
|
|
|
|
NL292958A
(enExample)
|
1962-05-29 |
1900-01-01 |
|
|
|
GB8809205D0
(en)
|
1988-04-19 |
1988-05-25 |
Nye P C G |
Treatment of oedema
|
|
US5137871A
(en)
|
1989-07-28 |
1992-08-11 |
Regents Of The University Of California |
Treatment to reduce edema for brain and musculature injuries
|
|
DE4010536A1
(de)
*
|
1990-04-02 |
1991-10-10 |
Boehringer Mannheim Gmbh |
Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure
|
|
US5486530A
(en)
|
1991-04-27 |
1996-01-23 |
Boehringer Mannheim Gmbh |
Use of torasemide for the treatment of brain oedemas
|
|
DE4113820A1
(de)
|
1991-04-27 |
1992-10-29 |
Boehringer Mannheim Gmbh |
Verwendung von torasemid zur behandlung von hirnoedemen
|
|
US5741671A
(en)
|
1991-12-12 |
1998-04-21 |
The Johns Hopkins University |
Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1)
|
|
US5858702A
(en)
|
1991-12-13 |
1999-01-12 |
The Johns Hopkins University |
Isolation, cloning and expression of transmembrane water channel Aquaporin 5 (AQP5)
|
|
US5519035A
(en)
|
1993-07-02 |
1996-05-21 |
Cornell Research Foundation, Inc. |
Treatment of stroke or in anticipation of the occurrence of brain ischemia
|
|
US20060167110A1
(en)
|
1995-01-13 |
2006-07-27 |
Blume Cherly D |
Methods for treating cerebrovascular disease by administering desmethylselegiline
|
|
WO1998021951A1
(en)
|
1996-11-18 |
1998-05-28 |
Emisphere Technologies, Inc. |
Methods and compositions for inducing oral tolerance in mammals
|
|
EP1005347A4
(en)
|
1997-08-06 |
2002-08-28 |
Smithkline Beecham Corp |
ANTAGONISTS OF THE RECEPTORS OF THE MONOCYTE MACROPHAGE FOR USE IN TREATING CARDIOVASCULAR DISEASES
|
|
US5905090A
(en)
|
1998-04-29 |
1999-05-18 |
Italfarmaco S.P.A. |
Analogues of the active metabolite of leflunomide
|
|
CO5180581A1
(es)
*
|
1999-09-30 |
2002-07-30 |
Pfizer Prod Inc |
Compuestos para el tratamiento de la isquemia ciones farmaceuticas que los contienen para el tratamiento de la isquemia
|
|
US6500809B1
(en)
|
1999-11-12 |
2002-12-31 |
Neuron Therapeutics, Inc. |
Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith
|
|
DK1106614T3
(da)
|
1999-12-10 |
2004-04-13 |
Pfizer |
5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
|
|
WO2002049632A1
(en)
|
2000-12-18 |
2002-06-27 |
Institute Of Medicinal Molecular Design. Inc. |
Inhibitors against the production and release of inflammatory cytokines
|
|
ES2807274T3
(es)
|
2002-03-20 |
2021-02-22 |
Univ Maryland |
Un canal catiónico no selectivo en células neurales y compuestos que bloquean el canal para su uso en el tratamiento de la inflamación del cerebro
|
|
US8980952B2
(en)
|
2002-03-20 |
2015-03-17 |
University Of Maryland, Baltimore |
Methods for treating brain swelling with a compound that blocks a non-selective cation channel
|
|
WO2003103658A1
(ja)
|
2002-06-05 |
2003-12-18 |
株式会社医薬分子設計研究所 |
免疫関連プロテインキナーゼ阻害剤
|
|
EA009523B1
(ru)
|
2002-06-05 |
2008-02-28 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Ингибиторы в отношении активации ар-1 и nfat
|
|
CA2488342A1
(en)
|
2002-06-05 |
2003-12-18 |
Institute Of Medicinal Molecular Design, Inc. |
Therapeutic drug for diabetes
|
|
US7626042B2
(en)
|
2002-06-06 |
2009-12-01 |
Institute Of Medicinal Molecular Design, Inc. |
O-substituted hydroxyaryl derivatives
|
|
AU2003242103A1
(en)
|
2002-06-06 |
2003-12-22 |
Institute Of Medicinal Molecular Design, Inc |
Antiallergic agents
|
|
EP1535609A4
(en)
|
2002-06-10 |
2009-01-07 |
Inst Med Molecular Design Inc |
Nf-kb activation inhibitors
|
|
EA010835B1
(ru)
|
2002-06-10 |
2008-12-30 |
Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. |
Лекарственное средство для лечения рака
|
|
US20060035944A1
(en)
|
2002-06-11 |
2006-02-16 |
Susumu Muto |
Remedies for neurodegenerative diseases
|
|
EP1542699A4
(en)
|
2002-07-15 |
2009-03-25 |
Myriad Genetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
|
|
DK1590458T3
(da)
|
2003-02-06 |
2013-02-04 |
Univ Belfast |
Bradykinin B2-receptorantagonistpeptid fra amfibiehud
|
|
SI1617834T1
(sl)
|
2003-05-01 |
2007-02-28 |
Innogene Kalbiotech Pte Ltd |
Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe
|
|
US20070042997A1
(en)
|
2003-07-16 |
2007-02-22 |
Akiko Itai |
Medicament for treatment of dermal pigmentation
|
|
US7598412B2
(en)
*
|
2003-10-08 |
2009-10-06 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
|
US8467876B2
(en)
|
2003-10-15 |
2013-06-18 |
Rmx, Llc |
Breathing disorder detection and therapy delivery device and method
|
|
US20070254956A1
(en)
|
2003-10-29 |
2007-11-01 |
Koichi Shudo |
Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation
|
|
US7378509B2
(en)
|
2003-12-02 |
2008-05-27 |
Anesiva, Inc. |
NF-kappaB oligonucleotide decoy molecules
|
|
US10583094B2
(en)
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
|
JP5085326B2
(ja)
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド，ボルチモア |
ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
|
|
US7601745B2
(en)
|
2004-09-27 |
2009-10-13 |
4Sc Ag |
Heterocyclic NF-kB inhibitors
|
|
AU2006204146A1
(en)
|
2005-01-04 |
2006-07-13 |
Novartis Ag |
Biomarkers for identifying efficacy of tegaserod in patients with chronic constipation
|
|
MY147790A
(en)
|
2005-04-28 |
2013-01-31 |
Takeda Pharmaceutical |
Stable emulsion composition
|
|
WO2007084464A2
(en)
|
2006-01-17 |
2007-07-26 |
The University Of North Carolina At Chapel Hill |
Water channel blockers and methods of use thereof
|
|
JP4273235B2
(ja)
*
|
2006-06-01 |
2009-06-03 |
国立大学法人 新潟大学 |
アクアポリン４阻害薬
|
|
JP2009539870A
(ja)
|
2006-06-06 |
2009-11-19 |
ジェネンテック・インコーポレーテッド |
血管発生の調節ための組成物および方法
|
|
AU2007319672B2
(en)
|
2006-06-06 |
2011-06-30 |
Genentech, Inc. |
Anti-DLL4 antibodies and methods using same
|
|
US7671058B2
(en)
|
2006-06-21 |
2010-03-02 |
Institute Of Medicinal Molecular Design, Inc. |
N-(3,4-disubstituted phenyl) salicylamide derivatives
|
|
US10004703B2
(en)
|
2006-10-12 |
2018-06-26 |
Biogen Chesapeake Llc |
Treatment of alzheimer's disease using compounds that reduce the activity of non-selective CA++ activated ATP-sensitive cation channels regulated by SUR1 channels
|
|
US20100056444A1
(en)
|
2006-10-12 |
2010-03-04 |
Sven Martin Jacobson |
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
|
|
EP2086329B1
(en)
|
2006-10-26 |
2014-07-23 |
The Arizona Board of Regents on behalf of the University of Arizona |
Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
|
|
US9316633B2
(en)
|
2006-11-16 |
2016-04-19 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
|
US20080171719A1
(en)
|
2006-11-28 |
2008-07-17 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
US20080214486A1
(en)
|
2006-11-28 |
2008-09-04 |
Alcon Manufacturing, Ltd. |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
|
|
WO2008089103A2
(en)
|
2007-01-12 |
2008-07-24 |
University Of Maryland, Baltimore |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
SG178716A1
(en)
|
2007-01-16 |
2012-03-29 |
Ipintl Llc |
Novel composition for treating metabolic syndrome
|
|
US20120183600A1
(en)
*
|
2007-01-16 |
2012-07-19 |
Chien-Hung Chen |
Novel composition for treating metabolic syndrome and other conditions
|
|
US20100092469A1
(en)
|
2007-02-09 |
2010-04-15 |
Simard J Marc |
Antagonists of a non-selective cation channel in neural cells
|
|
EP2543249B1
(en)
|
2007-02-17 |
2018-05-23 |
President and Fellows of Harvard College |
Compositions and method for tissue preservation
|
|
TW200848063A
(en)
|
2007-04-23 |
2008-12-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CA2691199C
(en)
|
2007-06-22 |
2017-09-12 |
Marc J. Simard |
Inhibitors of ncca-atp channels for therapy
|
|
AU2008272818A1
(en)
*
|
2007-07-02 |
2009-01-08 |
Yu, Ming Dr |
Methods, composition, targets for combinational cancer treatments
|
|
US20090239868A1
(en)
|
2007-10-23 |
2009-09-24 |
Institute Of Medical Molecular Design, Inc. |
Inhibitor of pai-1 production
|
|
WO2009054439A1
(ja)
|
2007-10-23 |
2009-04-30 |
Institute Of Medicinal Molecular Design, Inc. |
Pai-1産生抑制剤
|
|
CA3123813C
(en)
|
2007-12-04 |
2024-10-08 |
Remedy Pharmaceuticals, Inc. |
IMPROVED GLIBENCLAMIDE FORMULATIONS AND RELATED FREEZE-DRYING METHODS, AND FREEZE-DRY SATE PRODUCED THUS
|
|
GB0724340D0
(en)
|
2007-12-13 |
2008-01-30 |
Univ Dundee |
Novel Therapeutic Agents
|
|
AU2008345225A1
(en)
*
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009097443A2
(en)
|
2008-01-29 |
2009-08-06 |
Remedy Pharmaceuticals, Inc. |
Liquid formulations of compounds active at sulfonylurea receptors
|
|
US8211882B2
(en)
|
2008-03-08 |
2012-07-03 |
Richard Delarey Wood |
Glutamate receptor modulators and therapeutic agents
|
|
US20090286799A1
(en)
|
2008-05-16 |
2009-11-19 |
Zhi-Gang Jiang |
Methods for the treatment of brain edema
|
|
US20110263478A1
(en)
|
2008-09-16 |
2011-10-27 |
Simard J Marc |
Sur1 inhibitors for therapy
|
|
US20120010178A1
(en)
|
2008-10-21 |
2012-01-12 |
President And Fellows Of Harvard College |
Methods and compounds for treatment of neurodegenerative disorders
|
|
GB0823366D0
(en)
|
2008-12-22 |
2009-01-28 |
Uni I Oslo |
Synthesis
|
|
CN102348668B
(zh)
|
2009-01-12 |
2014-11-19 |
培力有限公司 |
化合物及其用于治疗炎症和调节免疫应答的用途
|
|
US20120039805A1
(en)
|
2009-02-20 |
2012-02-16 |
Pangea Biosciences, Inc. |
Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
|
|
KR101800040B1
(ko)
|
2010-03-10 |
2017-11-21 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
릴랙신을 사용한 아쿠아포린의 조절
|
|
CA2806069C
(en)
|
2010-07-19 |
2021-01-19 |
Remedy Pharmaceuticals, Inc. |
Methods of intravenous administration of glyburide and other drugs
|
|
JP2013535457A
(ja)
*
|
2010-07-28 |
2013-09-12 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系及び炎症性疾患の治療用医薬組成物
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
EP2685972A4
(en)
|
2011-03-14 |
2014-08-13 |
Io Therapeutics Inc |
TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES WITH RAR ALPHA SELECTIVE AGONISTS
|
|
ES2622112T3
(es)
|
2011-05-02 |
2017-07-05 |
Stichting Vumc |
Protección contra la disfunción de la barrera endotelial a través de la inhibición del gen relacionado con la tirosina
quinasa Abl (ARG)
|
|
RU2461375C1
(ru)
*
|
2011-05-19 |
2012-09-20 |
Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) |
Способ комбинированного лечения больных местно-распространенным раком желудка
|
|
WO2013152313A1
(en)
*
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
US9452973B2
(en)
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
CN104602682B
(zh)
|
2012-05-08 |
2018-12-14 |
埃罗米克斯公司 |
用于治疗水通道蛋白介导的疾病的化合物
|
|
JP6083770B2
(ja)
|
2013-09-13 |
2017-02-22 |
昭子 板井 |
水溶液製剤及びその製造方法
|
|
EP3065729A4
(en)
|
2013-11-06 |
2017-05-31 |
Aeromics, Inc. |
Novel formulations
|
|
SG11201604477SA
(en)
|
2013-12-13 |
2016-07-28 |
Vertex Pharma |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
AU2015346076A1
(en)
|
2014-11-13 |
2017-06-15 |
Aeromics, Inc. |
Novel methods
|
|
CN108348567B
(zh)
|
2015-05-29 |
2022-03-01 |
马里兰州立大学巴尔的摩分校 |
减少或预防由内皮细胞的机械刺激所致的内膜损伤的方法
|
|
KR20240105519A
(ko)
|
2015-10-07 |
2024-07-05 |
레메디 파마슈티칼즈, 인크. |
Cns 부종과 관련한 손상 또는 병태의 치료 방법
|
|
AU2017261828B2
(en)
|
2016-05-13 |
2023-04-13 |
Aeromics, Inc. |
Crystals
|
|
JP7165648B2
(ja)
|
2016-07-29 |
2022-11-04 |
バイオジェン チェサピーク エルエルシー |
Ｓｕｒ１－ｔｒｐｍ４チャネル阻害剤による医療処置方法
|
|
BR112023002129A2
(pt)
|
2020-08-05 |
2023-04-18 |
Jiangsu Simcere Pharm Co Ltd |
Composição farmacêutica de inibidor de aquaporina e método de preparação da mesma
|